The “Psychedelics Avant-gardes” webinar is a precursor to the Italian General Assembly of the Associazione Luca Coscioni. The anticipated audience comprises congress members, experts from various domains (including psychologists, psychiatrists, jurists, and decision-makers), as well as the general public.

• Dr. Reid Robison, MD, MBA | Numinus Chief Clinical Officer
  Psychedelic therapies, tracing their historical context, presenting current medications and treatments. He will emphasize the role of set and setting, and explain the standard therapeutic models in use. 

• Sharan Sidhu | Numinus VP, Scientific Research and Innovation
  The regulatory landscape of psychedelic therapies in the US and Canada, offering insights into the legal challenges and advancements in both countries. Additional details on SAP in Canada as it pertains to psychedelic-assisted therapies.

• Dr. Evan Lewis, MD, FRCPC, CSCN EEG | Numinus VP, Psychedelic Neurology
  Psychedelic mechanisms and psychedelics for Functional neurological disorder (FND). He will give background on FND, need, and prevalence stats in Italy. He will then describe psychedelic use to treat FND.

• Federico Menapace | Deputy Director at Multidisciplinary Association for Psychedelic Studies (MAPS)
  MDMA Federal approval and changes in U.S. policies.

• Tadeusz Hawrot | Founder & Executive Director, Psychedelic Access and Research European Alliance (PAREA)
  European progress and perspectives on Psychedelics research and possible therapeutic uses.

• Théo Giubilei | Founder of the PsychedeliCare European Citizens’ Initiative
  The PsychedeliCare Initiative – Presentation of the first Citizens’ Initiative for the medical use of psychedelics in the EU.